https://www.selleckchem.com/pr....oducts/tiplaxtinin-p
The technological approach led to a satisfactory process yield (71.5%), encapsulation efficiency (99.9%), and stability. The in vitro water dissolution rate of the bioactive compounds appeared to be improved with respect to the extract, suggesting higher feasibility in the manufacturing and administration; even the in vitro biological activity of the produced multi-component AJEP3 was clearly enhanced. To investigate antibody production in asymptomatic and mild COVID-19 patients. Sera from asymptomatic to severe COVID-19 pat
Like
Comment
Share
